Brain scans: (L) Creutzfeldt-Jakob disease, and (R) Aphasia

by Dee McLachlan

Almost a year ago, I wrote an article entitled “Could the Next Global Crisis in 2022-23 be a Prion (Mad Cow Disease) Pandemic?” (April 27, 2021). Probably an over-the-top title, but I quoted from Steve Bannon’s interview with Dr Richard Flemming (14 April 2021). At 8:30, Dr Flemming said:

“The spike protein [produced by the vaccine] is not natural; it is gain of function. It is crossing the blood-brain barrier and we know in the animal models… in the humanized mice it forms spongiform encephalopathy … for the general public that’s mad cow disease. We also know in the rhesus macaque models that about two weeks afterward they developed Lewy Body and inflammation in the brain and Lewy bodies is what causes Alzheimer’s and a number of neurological disorders and those numbers translate into about a year and a half for human beings to see the same consequences…”

CJD

From fact sheet on the NIH:

“Creutzfeldt-Jakob disease (CJD) is a rare, degenerative, fatal brain disorder. …CJD usually appears in later life and runs a rapid course. Typical onset of symptoms occurs at about age 60, and about 70 percent of individuals die within one year.”

And from NSW Health:

“Classical CJD occurs in Australia and about one in one million people per year… About 90% of classical CJD cases occur by chance (sporadic CJD) and 10% of cases are hereditary (familial or inherited CJD)…

“Variant CJD, is a disease that emerged in the UK in the 1990s …linked to the consumption of meat products from cattle infected with bovine spongiform encephalopathy (BSE, or “mad cow disease”).”

There have been very sad and terrible reports of people dying from Creutzfeldt-Jakob Disease (CJD) post-vaccine. I will cover two stories here. The first was reported in The Defender — an exclusive interview with Richard Sprague who said his wife, Jennifer, developed CJD after the Pfizer COVID-19 shot, dying five months later.

Jennifer Deason Sprague

Source https://childrenshealthdefense.org/defender